弱温度刺激荷重運動視標追跡検査法と反復検査法からみためまい発現機構の解析 : めまい・平衡障害例に対するβ-交感神経刺激剤とCo-enzyme Qの治療成績からの検討を中心に

概要

論文の詳細を見る
The data obtained in patients with vertigo and equilibrium disorders following β-adrenergic stimulant (dl-isoproterenol hydrochloride) and Co-enzyme Q (Ubiquinone) administration indicated that vertiginous attacks in these patients probably were the results of enhancement of the β-sympathetic system.<BR>The regional action of β-sympathetic system in β-adrenergic stimulant administration was more likely to appear with changes in excitability of the unilateral vestibular organ (in Menieres disease) other than static dysfunction (in sensorineural hearing loss and equilibrium disorders) and effectively provided relief for the symptoms of Menieres disease. Attacks of vertigo did follow in some patients.<BR>On the other hand, the uniform mass discharge in the sympathetic system was likely to appear in cases of β-adrenergic stimulant administration to patients with bilateral positive findings in The Mild Caloric Eye Tracking Pattern and Repeated Mild Caloric Eye tracking Pattern Tests.<BR>The results (the superimposed phenomena) in these tests revealted indications of β-adrenergic stimulant and Co-enzyme Q administration to patients with vertigo and equilibrium disorders.